Drug Interaction in Infectious Diseases


The medical hurt which may be majorly prevented is drug interactions within the infectious diseases. Drug interactions represent a serious risk to patients. The approved drug product labels for anti-infective medication, direct-acting antivirals for HCV, HIV medication unveil that drug interactions gift an enormous challenge for patients and their attention suppliers. Non-CYP enzymes, CYP enzymes, and changes in stomachic pH, the ever-growing list of drug transporters could also be the reason behind interactions. There are alternative concerns that incorporate interactions thanks to food parts, flavouring medications and biological merchandise.



 


  • Fluoxetine and Phenelzine
  • Digoxin and Quinidine
  • Warfarin and Diflunisal
  • Theophylline and Ciprofloxacin

Related Conference of Drug Interaction in Infectious Diseases

March 13-14, 2025

9th International Conference on Rare Diseases

Prague, Czech Republic
March 17-18, 2025

12th International Congress on Infectious Diseases

Berlin, Germany
April 14-15, 2025

15th European Epidemiology and Public Health Congress

Budapest, Hungary
June 02-03, 2025

14th World Congress on Rare Diseases and Orphan Drugs

Amsterdam, Netherlands
June 02-03, 2025

17th Euro-Global Conference on Infectious Diseases

Amsterdam, Netherlands

Drug Interaction in Infectious Diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in